Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


NeoStem: The Best Upside In An Innovating Space 

 

NeoStem: The Best Upside In An Innovating Space
Seeking Alpha
With only one approved product that has a cell therapy as its main component, the potential for new treatments and the outlook for those treatments is at an all-time high. The valuation for companies in this space is particularly attractive, perhaps ...
See all stories on this topic »

 

Posted on 18-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: